Thursday 21 July 2011
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2011
(306)
-
▼
July
(19)
- Novasep's Freeport, Bahamas, and Chasse sur Rhône,...
- Currency puts pressure on Lonza
- Sigma-Aldrich's SAFC business unit reported sales ...
- Laureate Biopharma will develop and manufacture a ...
- Lonza will provide process development and scale-u...
- WH Partnership will provide specialist engineering...
- Albemarle's Fine Chemistry sales rose 31% to $184....
- Cellectis reaches Lonza milestone
- Lonza will produce phase II clinical trial materia...
- Johnson Matthey's Fine Chemicals Division sales ro...
- Lonza has started its buyout of Arch
- Ajinomoto and Granules announce API jv
- Mark Griffiths has been appointed as Chief Executi...
- Lonza to buy Arch
- FDA approves 20 drugs in H1
- Angel Biotechnology has signed a revised contract ...
- OctoPlus will provide process development and manu...
- Recipharm spins out biologics facilities
- Unions call for Lonza talks
-
▼
July
(19)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment